Morgan Stanley analysts have picked out five UK cyclical stocks they said have “significant potential upside” in the event of an expected coronavirus vaccine-led market recovery.

“The valuation case for UK equities is compelling,” the client note from Morgan Stanley equity analyst Matthew Garman said.